Singapore markets close in 7 hours 41 minutes
Straits Times Index
3,307.72 +10.83 (+0.33%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,207.13 +444.10 (+2.50%) FTSE 100
8,172.15 +50.91 (+0.63%) Bitcoin USD
59,265.64 +1,539.94 (+2.67%) CMC Crypto 200
1,273.37 +2.62 (+0.21%)
ABT Jan 2026 60.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:02AM EDT. Market open.
| Previous close | 61.55 |
| Open | N/A |
| Bid | 53.50 |
| Ask | 58.50 |
| Strike | 60.00 |
| Expiry date | 2026-01-16 |
| Day's range | 61.55 - 61.55 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.